vs
Side-by-side financial comparison of EyePoint, Inc. (EYPT) and Navitas Semiconductor Corp (NVTS). Click either name above to swap in a different company.
Navitas Semiconductor Corp is the larger business by last-quarter revenue ($8.6M vs $5.3M, roughly 1.6× EyePoint, Inc.). On growth, Navitas Semiconductor Corp posted the faster year-over-year revenue change (-38.7% vs -43.7%). Over the past eight quarters, Navitas Semiconductor Corp's revenue compounded faster (-35.2% CAGR vs -40.8%).
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
Navitas Semiconductor Corp is a leading global semiconductor firm specializing in gallium nitride (GaN) power integrated circuits. Its high-efficiency, compact power solutions serve consumer electronics, electric vehicles, renewable energy, and industrial sectors, with clients spanning North America, Asia, and Europe.
EYPT vs NVTS — Head-to-Head
Income Statement — Q2 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $5.3M | $8.6M |
| Net Profit | $-59.4M | — |
| Gross Margin | — | 98.6% |
| Operating Margin | -1166.8% | -260.6% |
| Net Margin | -1114.3% | — |
| Revenue YoY | -43.7% | -38.7% |
| Net Profit YoY | -92.8% | — |
| EPS (diluted) | $-0.85 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $8.6M | ||
| Q4 25 | — | $7.3M | ||
| Q3 25 | — | $10.1M | ||
| Q2 25 | $5.3M | $14.5M | ||
| Q1 25 | $24.5M | $14.0M | ||
| Q4 24 | $11.6M | $18.0M | ||
| Q3 24 | $10.5M | $21.7M | ||
| Q2 24 | $9.5M | $20.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-31.8M | ||
| Q3 25 | — | $-19.2M | ||
| Q2 25 | $-59.4M | $-49.1M | ||
| Q1 25 | $-45.2M | $-16.8M | ||
| Q4 24 | $-41.4M | $-39.9M | ||
| Q3 24 | $-29.4M | $-18.7M | ||
| Q2 24 | $-30.8M | $-22.3M |
| Q1 26 | — | 98.6% | ||
| Q4 25 | — | 38.1% | ||
| Q3 25 | — | 37.9% | ||
| Q2 25 | — | 16.1% | ||
| Q1 25 | — | 37.9% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | 93.0% | 39.7% | ||
| Q2 24 | 85.2% | 39.0% |
| Q1 26 | — | -260.6% | ||
| Q4 25 | — | -567.3% | ||
| Q3 25 | — | -192.0% | ||
| Q2 25 | -1166.8% | -149.4% | ||
| Q1 25 | -199.7% | -180.5% | ||
| Q4 24 | -390.4% | -216.9% | ||
| Q3 24 | -311.2% | -133.6% | ||
| Q2 24 | -364.5% | -152.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | -436.1% | ||
| Q3 25 | — | -190.2% | ||
| Q2 25 | -1114.3% | -338.7% | ||
| Q1 25 | -184.8% | -120.1% | ||
| Q4 24 | -357.3% | -221.7% | ||
| Q3 24 | -279.0% | -86.4% | ||
| Q2 24 | -325.3% | -109.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | $-0.14 | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | $-0.85 | $-0.25 | ||
| Q1 25 | $-0.65 | $-0.09 | ||
| Q4 24 | $-0.65 | $-0.22 | ||
| Q3 24 | $-0.54 | $-0.10 | ||
| Q2 24 | $-0.58 | $-0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $255.7M | $221.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $246.0M | $420.0M |
| Total Assets | $301.1M | $481.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $221.0M | ||
| Q4 25 | — | $236.9M | ||
| Q3 25 | — | $150.6M | ||
| Q2 25 | $255.7M | $161.2M | ||
| Q1 25 | $318.2M | $75.1M | ||
| Q4 24 | $370.9M | $86.7M | ||
| Q3 24 | $253.8M | $98.3M | ||
| Q2 24 | $280.2M | $111.7M |
| Q1 26 | — | $420.0M | ||
| Q4 25 | — | $443.7M | ||
| Q3 25 | — | $371.0M | ||
| Q2 25 | $246.0M | $388.9M | ||
| Q1 25 | $298.4M | $341.8M | ||
| Q4 24 | $336.5M | $348.0M | ||
| Q3 24 | $218.7M | $380.8M | ||
| Q2 24 | $228.3M | $388.1M |
| Q1 26 | — | $481.4M | ||
| Q4 25 | — | $500.5M | ||
| Q3 25 | — | $430.2M | ||
| Q2 25 | $301.1M | $449.4M | ||
| Q1 25 | $362.6M | $370.8M | ||
| Q4 24 | $418.5M | $390.0M | ||
| Q3 24 | $300.9M | $419.4M | ||
| Q2 24 | $324.2M | $439.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-62.6M | — |
| Free Cash FlowOCF − Capex | $-63.8M | — |
| FCF MarginFCF / Revenue | -1196.5% | — |
| Capex IntensityCapex / Revenue | 22.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-194.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $-8.1M | ||
| Q3 25 | — | $-10.0M | ||
| Q2 25 | $-62.6M | $-11.2M | ||
| Q1 25 | $-53.1M | $-13.5M | ||
| Q4 24 | $-35.8M | $-10.2M | ||
| Q3 24 | $-39.0M | $-13.7M | ||
| Q2 24 | $-20.2M | $-15.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-8.2M | ||
| Q3 25 | — | $-10.7M | ||
| Q2 25 | $-63.8M | $-11.9M | ||
| Q1 25 | $-53.4M | $-13.6M | ||
| Q4 24 | $-36.2M | $-10.8M | ||
| Q3 24 | $-40.6M | $-14.3M | ||
| Q2 24 | $-21.1M | $-17.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | -111.8% | ||
| Q3 25 | — | -106.1% | ||
| Q2 25 | -1196.5% | -82.2% | ||
| Q1 25 | -218.4% | -96.8% | ||
| Q4 24 | -312.7% | -59.8% | ||
| Q3 24 | -385.8% | -65.9% | ||
| Q2 24 | -222.4% | -87.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.7% | ||
| Q3 25 | — | 7.0% | ||
| Q2 25 | 22.9% | 4.7% | ||
| Q1 25 | 1.1% | 0.3% | ||
| Q4 24 | 3.3% | 3.1% | ||
| Q3 24 | 15.0% | 2.6% | ||
| Q2 24 | 9.5% | 13.4% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
